Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-447899

President, Oncology sold 8,333 shares at an average $80.89 ($674,069)

  • President, Oncology acquired 8,333 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Vieira Roberto Wandenkolk · President, Oncology

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-02 Exercise or conversion : show line 1 in the form 10b5-1 +8,333 $21.63 $180,243 12,279 D
2026-11-02 Sale : show line 2 in the form 10b5-1 −6,657 $80.73 $537,437 5,622 D
2026-11-02 Sale : show line 3 in the form 10b5-1 −1,676 $81.52 $136,632 3,946 D
Open-market sales · 8,333 sh · avg $80.89 · $674,069

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-02 Exercise or conversion : show line 4 in the form 10b5-1 Stock option (right to buy) −8,333 125,001 D
Loading xslF345X06/ownership.xml…